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Preface   -   Generalised musculoskeletal problems 
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The last decades have witnessed enormous progress in understanding the pathogenic mechanisms 
of rheumatic diseases. Based on the findings new paradigms in the treatment of many rheumatic 
diseases could be established leading to an improvement in the outcome of rheumatic diseases that 
was not conceivable at the end of the last century. However, in recent years many studies revealed a 
gap between the perceived (and measured) disease activity and various other parameters best 
summarized as patient reported outcomes (PRO). The PRO such as pain, fatigue, sleep quality and 
quality of life are getting more attention since regulatory agencies, e.g. FDA as well as EMA, require 
PRO to be included in clinical studies for approval of new treatments. 
 
In this context, we asked experts in their field to provide a State of the Art  article being well aware 
that our selection of topics is eclectic. However, from a patient's point of view pain is the major 
concern after being diagnosed with a rheumatic disease. Therefore, pain is in the centre of a few 
articles in this issue. Anne-Priscille Trouvin and Serge Perrot will introduce the latest concepts 
concerning pathophysiology of pain followed by an article from Martin Diers who present the latest 
data on neuroimaging of pain. We all are aware of the clinical phenomenon that in quite a few 
patients with inflammatory rheumatic diseases pain persists despite successful treatment of the 
inflammation.  Therefore, Jon Lampa discusses pain modalities in rheumatic diseases without 
obvious inflammatory changes. Finally, a chapter, authored by Christoph Stein an Andreas Kopf, 
focuses on the latest medical developments for chronic pain states. 
 
A second focus of this issue is on the various aspects ofmyalgia. The basis is laid by the chapter from 
Stefanie Glaubitz, Karsten Schmidt, Jana Zschüntzsch, and Jens Schmidt who address the latest 
diagnostic criteria and therapeutic advancements in myositis and myopathies. Since fibromyalgia 
syndrome (FMS) is one of the most common conditions that rheumatologists will encounter Sizheng 
Steven Zhao, Stephen J Duffield, and Nicola J Goodson provide perspective to FMS as a comorbid 
condition in rheumatic diseases and the influence of FMS on clinical outcome parameters as well as 
PRO. Martijn Oude Voshaar and Mart van de Laar devote a chapter to the latest developments of 
core set recommendations for assessing patient reported outcomes including measurement 
precision of PRO and the increasing use of item response theory based approaches in PRO 
assessments. Winfried H€auser and Gareth Jones are tackling the task to reviewthe mechanisms of 
actions and the evidence on efficacy, tolerability and safety of psychological therapy in FMS and 
chronic widespread pain.   
 
A major component of FMS is fatigue. However, fatigue can occur independently in an individual 
patient. Olga Seifert et al. discuss the concept of fatigue and the role of fatigue for the patients’ 
quality of life. Closely relate to fatigue is the quality of sleep. In this respect, Tobias Boeselt and 
colleagues present a comprehensive review of sleep disturbances in rheumatic diseases. 
 
We hope that the reader enjoys and learn from the writings of our experts. Furthermore, we would 
like to take this opportunity to thank the authors for their contributions to this publication. 
 
 
